Antibody Responses and Protection in Mice Immunized with Herpes Simplex Virus Type 1 Antigen Immune-stimulating Complex Preparations

References

1. Allison A. C., Byars N. E. 1986; An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. Journal of Immunological Methods 95:157–168
   [Google Scholar]
2. Ashley R., Mertz G., Clark C, Schick M., Salter D., Corey L. 1985; Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine. Journal of Virology 56:475–481
   [Google Scholar]
3. Blyth W. A., Harbour D. A., Hill T. J. 1984; Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. Journal of General Virology 65:1477–1486
   [Google Scholar]
4. Cappel R., Sprecher S., De Cuyper F. 1982; Immune responses of free herpes simplex proteins in man. Developments in Biological Standardization 52:345–350
   [Google Scholar]
5. De Vries P., Van Binnendijk R. S., Van Der Marel P., Van Wezel A. L., Voorma H. A., Sundquist B., Uytdehaag F. G. C. M., Osterhaus A. D. M. E. 1988; Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. Journal of General Virology 69:549–559
   [Google Scholar]
6. Ertürk M., Welch M. J., Jennings R., Phillpotts R. J. 1989; Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents. Vaccine in press
   [Google Scholar]
7. Jennings R., Quasim T., Sharrard R. M., Hockley D., Potter C. W. 1988; Zwitterionic detergent solubilization of HSV-1 surface antigens. Archives of Virology 98:137–153
   [Google Scholar]
8. Klein R. J. 1982; The pathogenesis of acute, latent and recurrent herpes simplex virus infections. Archives of Virology 72:143–168
   [Google Scholar]
9. Kutinova L., Bendu R., Kalos Z., Dbaly V., Votruba T., Kvicalova E., Petrovska P., Doutlik S., Kaminkova J., Domorazkova E., Bermanova V., Kremar M., Suchankova A., Nemeckova S., Vonka V. 1988; Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from herpetic recurrences. Vaccine 6:223–228
   [Google Scholar]
10. Lowry O., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
11. Mathiesen T., Persson M. A. A., Sundquist V.-A, Wahren B. 1988; Neutralization capacity and antibody-dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex virus. Clinical and Experimental Immunology 72:211–215
    [Google Scholar]
12. Meignier B., Jourdier T. M., Norrild B., Pereira L., Roizman B. 1987; Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection and challenge with virulent virus. Journal of Infectious Diseases 155:921–930
    [Google Scholar]
13. Merza M. S., Linne T., Hoglund S., Portetelle D., Burny A., Morein B. 1989; Bovine leukaemia virus ISCOMs: biochemical characterization. Vaccine 7:22–28
    [Google Scholar]
14. Morein B. 1988; The iscom antigen-presenting system. Nature London: 332287–288
    [Google Scholar]
15. Morein B., Sundquist B., Hoglund S., Dalsgaard K., Osterhaus A. 1984; Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature London: 308457–460
    [Google Scholar]
16. Morgan A. J., Finerty S., Lovgren K., Scullion F. T., Morein B. 1988; Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes. Journal of General Virology 69:2093–2096
    [Google Scholar]
17. Mougin B., Bakouche O., Gerlier D. 1988; Humoral immune response elicited in rats by measles virus membrane antigens presented in liposomes and iscoms. Vaccine 6:445–449
    [Google Scholar]
18. Mukhlis F. A., Jennings R., Stephenson T. J., Quasim T., Potter C. W. 1986; Characterization and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment. Vaccine 4:191–196
    [Google Scholar]
19. Sanchez-Pescador L., Burke R. L., Ott G., Van Nest G. 1988; The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine. Journal of Immunology 141:1720–1727
    [Google Scholar]
20. Skinner G. R. B., Williams D. R., Buchan A., Whitney J., Harding M., Bodfish K. 1978; Preparation and efficacy of an inactivated subunit vaccine (HSV BHK) against type 2 herpes simplex virus infection. Medical Microbiology and Immunology 166:119–132
    [Google Scholar]
21. Skinner G. R. B., Fink C. G., Cowan M., Buchan A., Fuller A., Hartley C E., Durham J., Wiblin C., Melling J. 1987; Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine. Medical Microbiology and Immunology 176:161–168
    [Google Scholar]
22. Stanberry L. R., Bernstein D. I., Burke R. L., Pachl C., Myers M. G. 1987; Vaccination against recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. Journal of Infectious Diseases 155:914–920
    [Google Scholar]
23. Sundquist B., Lovgren K., Hoglund S., Morein B. 1988; Influenza virus iscoms: biochemical characterization. Vaccine 6:44–48
    [Google Scholar]
24. Trudel M., Nadon F., Seguin C, Simard C., Lussier G. 1989; Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus. Vaccine 7:12–16
    [Google Scholar]
25. Van Landingham K. E., Marsteller H. B., Ross G. W., Hayden F. G. 1988; Relapse of herpes simplex encephalitis after conventional acylovir therapy. Journal of the American Medical Association 259:1051–1053
    [Google Scholar]